An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To confirm the pharmacokinetics following administration of gabapentin to Japanese subjects
with renal impairment, compare the results to Western study results and confirm the adaptive
possibility of dose adjustment in US package insert to Japanese.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.